1. New and Emerging Treatments for Cystic Fibrosis

   • Peter J. Barry
   • Andrew M. Jones

   Leading Article 20 June 2015 Pages: 1165 - 1175

2. Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)

   • Adam R. Thode
   • Robert A. Latkany

   Leading Article 01 July 2015 Pages: 1177 - 1185

3. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies

   • Richard Kones
   • Umme Rumana

   Review Article 27 June 2015 Pages: 1187 - 1199

4. Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs

   • Richard Kones
   • Umme Rumana

   Review Article 14 July 2015 Pages: 1201 - 1228

5. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future

   • Giuseppe De Luca
   • Stefano Savonitto
   • Harry Suryapranata

   Review Article 16 July 2015 Pages: 1229 - 1253

   

6. Acamprosate: A Review of Its Use in Alcohol Dependence

   • Greg L. Plosker

   Adis Drug Evaluation 18 June 2015 Pages: 1255 - 1268

   

7. Naltrexone ER/Bupropion ER: A Review in Obesity Management

   • Sarah L. Greig
   • Gillian M. Keating

   Adis Drug Evaluation 24 June 2015 Pages: 1269 - 1280

8. Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections

   • Lesley J. Scott

   Adis Drug Evaluation 24 June 2015 Pages: 1281 - 1291

9. Recombinant Human Parathyroid Hormone (1–84): A Review in Hypoparathyroidism

   • Esther S. Kim
   • Gillian M. Keating

   Adis Drug Evaluation 16 July 2015 Pages: 1293 - 1303

   

10. Eluxadoline: First Global Approval

    • Karly P. Garnock-Jones

    AdisInsight Report 07 July 2015 Pages: 1305 - 1310